Autopilot 2.0 Chain AI agents into full outbound flows Read more →
Product
AI Sales Agents Prospector Intent & Signals Visitor Tracking Reply Handler Email Automation LinkedIn Automation Autopilot
Solutions
TAM sourcing Automated outbound Sales RevOps Enterprise Startups
Resources
The Report Blog Salestools University Guides GPT Prompts ROI Calculator Help Center
Company
Our Team Careers Customers Partner Program Pricing Changelog
Language
Get a demo Start free trial Log in

Le rapport

Analyses approfondies du financement des entreprises, des stratégies de croissance et des insights de marché des entreprises les plus innovantes du monde

196 rapports et plus encore

Mis à jour quotidiennement avec les dernières informations de marché
Biotech
Eikon Therapeutics

Eikon Therapeutics raises $106M Series C at $1B valuation

Eikon Therapeutics raises $106M in Series C at $1B valuation. Biotech startup developing cancer-fighting therapeutic assets...

Editorial Team
Sep 22, 2024
0 min read•$106M
Fundraising
Eikon Therapeutics

Eikon Therapeutics Raises $350.7M in Series D

Eikon Therapeutics, a HealthTech company based in Hayward, CA, has raised $350.7M in Series D at a $3B valuation led by Andreessen Horowitz Bio, ARCH Venture Partners.

Fundraising News Team
Feb 1, 2025
0 min read
HealthTech
Eikon Therapeutics

Eikon Therapeutics raises $350.7M Series D at $3B valuation

Eikon Therapeutics raises $350.7M in Series D at $3B valuation. Drug discovery using advanced microscopy...

Editorial Team
Feb 1, 2025
0 min read•$350.7M
Biotech
Eikon Therapeutics

Eikon Therapeutics Raises $350.7M Series D to Transform Biotech

Eikon Therapeutics has secured $350.7M Series D in funding to accelerate growth and innovation in the biotech sector. Drug discovery company using advanced microscopy and computation to observe protein dynamics in living cells...

David Chen
Oct 22, 2025
0 min read•$350.7M Series D
HealthTech
Arnatar Therapeutics

Arnatar Therapeutics raises $52M Series A

Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...

Editorial Team
Aug 25, 2025
0 min read•$52M
Biotech
Denali Therapeutics

Denali Therapeutics raises $217M Series C at $5B valuation

Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...

Editorial Team
Mar 6, 2024
0 min read•$217M
HealthTech
Strand Therapeutics

Strand Therapeutics raises $153M Series B

Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...

Editorial Team
Sep 17, 2025
0 min read•$153M
Biotech
Seres Therapeutics

Seres Therapeutics raises $113M Series E at $450M valuation

Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...

Editorial Team
Jan 19, 2024
0 min read•$113M
Biotech
Crystalys Therapeutics

Crystalys Therapeutics raises $205M Series B at $900M valuation

Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...

Editorial Team
Oct 1, 2025
0 min read•$205M
Page 1

Affichage de 9 rapports • Page 1 • Catégorie : all

Restez en avance sur le marché

Recevez des insights hebdomadaires dans votre boîte de réception. Pas de spam, juste de l'intelligence.